• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

A Comparative Study on the Lot Release Systems for Vaccines as of 2016.

作者信息

Fujita Kentaro, Naito Seishiro, Ochiai Masaki, Konda Toshifumi, Kato Atsushi

机构信息

Department of Quality Assurance and Radiological Protection, National Institute of Infectious Diseases.

出版信息

Jpn J Infect Dis. 2017 Sep 25;70(5):565-570. doi: 10.7883/yoken.JJID.2017.133. Epub 2017 Jul 1.

DOI:10.7883/yoken.JJID.2017.133
PMID:28674319
Abstract

Many countries have already established their own vaccine lot release system that is designed for each country's situation: while the World Health Organization promotes for the convergence of these regulatory systems so that vaccines of assured quality are provided globally. We conducted a questionnaire-based investigation of the lot release systems for vaccines in 7 countries and 2 regions. We found that a review of the summary protocol by the National Regulatory Authorities was commonly applied for the independent lot release of vaccines, however, we also noted some diversity between countries, especially in regard to the testing policy. Some countries and regions, including Japan, regularly tested every lot of vaccines, whereas the frequency of these tests was reduced in other countries and regions as determined based on the risk assessment of these products. Test items selected for the lot release varied among the countries or regions investigated, although there was a tendency to prioritize the potency tests. An understanding of the lot release policy may contribute to improving and harmonizing the lot release system globally in the future.

摘要

相似文献

1
A Comparative Study on the Lot Release Systems for Vaccines as of 2016.
Jpn J Infect Dis. 2017 Sep 25;70(5):565-570. doi: 10.7883/yoken.JJID.2017.133. Epub 2017 Jul 1.
2
Study on the Procedure for Lot Release of Vaccines in Japan.日本疫苗批签发程序研究
Jpn J Infect Dis. 2019 May 23;72(3):133-141. doi: 10.7883/yoken.JJID.2018.446. Epub 2018 Nov 30.
3
Chinese vaccine products go global: vaccine development and quality control.中国疫苗产品走向全球:疫苗研发与质量控制。
Expert Rev Vaccines. 2015 May;14(5):763-73. doi: 10.1586/14760584.2015.1012503. Epub 2015 Feb 19.
4
Establishment of the 3rd national standard for lot release testing of the Japanese encephalitis vaccine (Nakayama-NIH strain) in Korea.韩国流行性乙型脑炎疫苗(中山-美国国立卫生研究院株)批签发检测第3项国家标准的制定。
Hum Vaccin Immunother. 2016 Jul 2;12(7):1805-7. doi: 10.1080/21645515.2016.1143994. Epub 2016 Feb 18.
5
New challenges in assuring vaccine quality.确保疫苗质量方面的新挑战。
Bull World Health Organ. 2000;78(2):155-62.
6
Acellular pertussis vaccines in China.中国的无细胞百日咳疫苗。
Vaccine. 2012 Nov 26;30(50):7174-8. doi: 10.1016/j.vaccine.2012.10.009. Epub 2012 Oct 19.
7
Speeding Access to Vaccines and Medicines in Low- and Middle-Income Countries: A Case for Change and a Framework for Optimized Product Market Authorization.加快低收入和中等收入国家的疫苗及药品获取:变革的理由与优化产品市场授权框架
PLoS One. 2016 Nov 16;11(11):e0166515. doi: 10.1371/journal.pone.0166515. eCollection 2016.
8
Vaccine quality--can a single standard be defined?疫苗质量——能否定义单一标准?
Vaccine. 2002 Jan 15;20(7-8):1000-3. doi: 10.1016/s0264-410x(01)00422-4.
9
Regulatory pathways for vaccines for developing countries.发展中国家疫苗的监管途径。
Bull World Health Organ. 2004 Feb;82(2):128-33. Epub 2004 Mar 16.
10
Standardization of the methods and reference materials used to assess virus content in varicella vaccines.评估水痘疫苗中病毒含量所使用方法和参考材料的标准化。
Virol J. 2015 Jul 5;12:101. doi: 10.1186/s12985-015-0333-1.